Nationwide Fund Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-793,710
Closed -$28.9M 680
2017
Q3
$28.9M Sell
793,710
-15,513
-2% -$592K 0.11% 185
2017
Q2
$31.9M Sell
809,223
-369,288
-31% -$13.5M 0.13% 164
2017
Q1
$37M Sell
1,178,511
-86,586
-7% -$2.71M 0.15% 128
2016
Q4
$39.5M Buy
1,265,097
+548,676
+77% +$17.8M 0.16% 105
2016
Q3
$28.8M Buy
716,421
+3
+0% +$113 0.12% 178
2016
Q2
$23.8M Sell
716,418
-204,372
-22% -$6.99M 0.1% 221
2016
Q1
$26.6M Sell
920,790
-13,476
-1% -$372K 0.12% 194
2015
Q4
$24.6M Buy
934,266
+274,980
+42% +$7.14M 0.11% 224
2015
Q3
$15.6M Buy
659,286
+277,536
+73% +$6.7M 0.07% 344
2015
Q2
$9.06M Buy
381,750
+26,550
+7% +$599K 0.04% 632
2015
Q1
$8.43M Buy
355,200
+153,864
+76% +$3.45M 0.03% 711
2014
Q4
$4.27M Buy
201,336
+5,736
+3% +$115K 0.02% 1024
2014
Q3
$3.33M Sell
195,600
-3,864
-2% -$61K 0.01% 1167
2014
Q2
$2.85M Sell
199,464
-18,312
-8% -$248K 0.01% 1274
2014
Q1
$2.69M Sell
217,776
-5,184
-2% -$59.8K 0.01% 1191
2013
Q4
$2.44M Sell
222,960
-1,346,502
-86% -$15.2M 0.01% 1354
2013
Q3
$18.2M Buy
1,569,462
+1,313,322
+513% +$15.4M 0.08% 288
2013
Q2
$2.87M Buy
+256,140
New +$3.03M 0.02% 1103

Other funds holding EW

Nationwide Fund Advisors's EW Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Edwards Lifesciences (EW) in Q4 2017, closing a stake of 793,710 shares — an estimated $28.9M sold.

Nationwide Fund Advisors first reported a position in EW in Q2 2013 and held it in 18 quarters. The position peaked at $39.5M in Q4 2016. 773 funds tracked by Wall St. Rank hold EW as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Edwards Lifesciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 793,710 Edwards Lifesciences shares in Q4 2017, an estimated $28.9M.
  • Nationwide Fund Advisors first reported a position in Edwards Lifesciences in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Edwards Lifesciences position peaked at $39.5M in Q4 2016.
  • 773 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.